Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Shares of UroGen Pharma Jumped Friday
Jim Halley
|
Jul 28, 2023
The company released positive top-line results for two studies for a bladder cancer treatment.
Why Shares of Phathom Pharmaceutical Jumped This Week
Jim Halley
|
Jan 28, 2023
Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy.
UroGen Pharma Ltd. (URGN) Q3 2020 Earnings Call Transcript
Motley Fool Transcribers
|
Nov 9, 2020
URGN earnings call for the period ending September 30, 2020.
UroGen Pharma Ltd. (URGN) Q2 2020 Earnings Call Transcript
Motley Fool Transcribers
|
Aug 10, 2020
URGN earnings call for the period ending June 30, 2020.
UroGen Pharma Ltd. (URGN) Q1 2020 Earnings Call Transcript
Motley Fool Transcribers
|
May 9, 2020
URGN earnings call for the period ending March 31, 2020.
UroGen Pharma Ltd. (URGN) Q4 2019 Earnings Call Transcript
Motley Fool Transcribers
|
Mar 2, 2020
URGN earnings call for the period ending December 31, 2019.
UroGen Pharma Ltd. (URGN) Q3 2019 Earnings Call Transcript
Motley Fool Transcribers
|
Nov 12, 2019
URGN earnings call for the period ending September 30, 2019.
Are These 3 Beaten-Down Biotech Stocks Bargains Now?
Cory Renauer
|
Oct 17, 2019
Some investors think the market's been too hard on these drugmakers.
Are the Shorts Right About This Clinical-Stage Pharma?
Maxx Chatsko
|
Sep 26, 2019
Investors walked away from UroGen Pharma after an article was published by a short-seller, but clinical results appear to favor the company.
UroGen Pharma Ltd. (URGN) Q2 2019 Earnings Call Transcript
Motley Fool Transcribers
|
Aug 12, 2019
URGN earnings call for the period ending June 30, 2019.
View More Articles